Andrew J. Barry

PerkinElmer (United States)

Papers

1

Total Citations

5

H-Index

1

About

Andrew J. Barry is a bioprocess engineer whose work has advanced the development of protein therapeutics through innovative purification strategies. His key research focuses on miniaturizing and automating downstream processing, particularly for monoclonal antibodies and other biotherapeutic molecules. Barry’s most notable contribution is his 2015 paper on automated small-scale protein purification, which demonstrated how parallel processing of miniaturized purification conditions can dramatically accelerate process development while improving statistical significance. This work has been cited 5 times and remains foundational for researchers seeking to reduce development timelines and material consumption. By enabling high-throughput screening of purification parameters, Barry’s approach allows scientists to evaluate more conditions with less sample, ultimately speeding the path from discovery to clinic. His research bridges the gap between laboratory-scale feasibility studies and commercial manufacturing, offering practical solutions for the biopharmaceutical industry. For students and researchers in bioprocess engineering, Barry’s work exemplifies how thoughtful automation and scale-down can transform protein therapeutic development.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Automated small‐scale protein purification and analysis for accelerated development of protein therapeutics
5 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: PerkinElmer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago